The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund focused on advancing the development of drugs, vaccines, diagnostics, and other health interventions that address diseases disproportionately affecting low- and middle-income countries. GHIF primarily supports late-stage innovations targeting public health challenges such as malaria, pre-eclampsia, cholera, HIV, and river blindness, with a strong emphasis on infectious diseases and maternal/infant health issues.